Jupiter Asset Management’s Emergent Biosolutions EBS Stock Holding History

Jupiter Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-103,410	Closed	-$352K	–	477
2023 Q3	$352K	Hold	103,410	–	–	﹤0.01%	448
2023 Q2	$759K	Sell	103,410 -245,668	-70%	-$2.28M	0.01%	445
2023 Q1	$3.61M	Buy	349,078 +131,779	+61%	+$1.59M	0.05%	236
2022 Q4	$2.56M	Buy	217,299 +201,869	+1,308%	+$3.12M	0.04%	282
2022 Q3	$324K	Buy	+15,430	New	+$429K	0.01%	471

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jupiter Asset Management's EBS Position: Q4 2023 in Review

Jupiter Asset Management sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 103,410 shares — an estimated $352K sold.

Jupiter Asset Management first reported a position in EBS in Q3 2022 and held it in 5 quarters. The position peaked at $3.61M in Q1 2023. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

Jupiter Asset Management reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
Jupiter Asset Management sold 103,410 Emergent Biosolutions shares in Q4 2023, an estimated $352K.
Jupiter Asset Management first reported a position in Emergent Biosolutions in Q3 2022 and held it in 5 quarters.
Jupiter Asset Management's Emergent Biosolutions position peaked at $3.61M in Q1 2023.
134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Jupiter Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.